FDA approves Novartis kidney disease drug

FDA Approves New Schizophrenia Drug in 70-Year 1st

FDA Approves Second Drug to Treat Rare Neurodegenerative Disease

The FDA approved IntraBio Inc.'s Aqneursa (levacetylleucine) yesterday for the treatment of ultra rare neurodegenerative disease Niemann-Pick Disease, Type C (NPC), according to a news release. This makes Aqneursa the second NPC drug approved within a week and the first standalone FDA-approved NPC treatment. Miplyffa gained approval last Friday.

Monthly Prescribing Reference · 20h

FDA Drug Approval Decisions Expected in November 2024

The Prescription Drug User Fee Act (PDUFA) date refers to the deadline set by the US Food and Drug Administration (FDA) for reviewing a New Drug

Newsweek · 6d

FDA Approves New Schizophrenia Drug in 70-Year First

The U.S. Food and Drug Administration has approved a new drug for ... causes of disability worldwide, the FDA reports. Individuals with this disease have a greater risk of dying young, and nearly ...

Reuters · 3d

US FDA approves GE HealthCare's diagnostic drug for heart disease

The U.S. Food and Drug Administration approved GE HealthCare's diagnostic drug for use in detection of coronary artery disease, the company said on Friday.

FOX News on MSN · 5d

New schizophrenia drug gets FDA approval, taking novel approach to treating brain disorder

On Thursday, the U.S. Food and Drug Administration approved COBENFY, an oral medication that marks the first new class of drugs for schizophrenia in more than 30 years.

Gizmodo · 6d

FDA Approves Potentially Groundbreaking Schizophrenia Drug

On Thursday, the Food and Drug Administration approved Cobenfy, a drug from Bristol Myers Squibb—the first truly novel treatment for schizophrenia in decades. We may earn a commission when you buy through links on our sites.

Investopedia · 6d

Bristol Myers Squibb Stock Rises After Schizophrenia Drug Gets FDA Approval

Bristol Myers Squibb shares rose Friday, a day after its schizophrenia drug was approved for use by the Food and Drug Administration.

Dailymotion on MSN · 5d

FDA Approves First Novel Schizophrenia Drug in 70 Years, Impacting Up to 3 Million Patients in...

The FDA has approved Bristol Myers Squibb’s new schizophrenia drug, Cobenfy, the first novel treatment for schizophrenia in over 70 years. Schizophrenia affects nearly 3 million U.S. adults, but only 1.

MedCity News27d

Full FDA Approval of Travere’s Kidney Drug Stiffens Competition With Novartis, Calliditas

A Travere Therapeutics drug for a rare disease that can progress to kidney failure has converted its status to full FDA approval ... them a Novartis drug recently awarded accelerated ...

FiercePharma28d

Despite trial scare, Travere's Filspari gains full FDA nod in kidney disease showdown with Novartis

The FDA has converted ... measure of kidney function, with elevated levels being associated with serious kidney disease. The drug was the first non-immunosuppressive drug approved for ...

C&EN6d

FDA approves Cobenfy, a first-in-class schizophrenia drug

The US Food and Drug Administration has approved Cobenfy ... and constipation. The FDA says people with known liver impairment or moderate to severe kidney impairment should not use the drug ...

STAT13d

FDA approves first drug for rare neuron disease, Niemann-Pick type C

Parents pushed for years for treatments for the neuron disease Niemann-Pick type C. After setbacks, one drug now has FDA ...

Morningstar7d

FDA Approves Drug with New Mechanism of Action for Treatment of Schizophrenia

SILVER SPRING, Md., Sept. 26, 2024 /PRNewswire/ -- Today, the U.S. Food and Drug Administration approved Cobenfy (xanomeline and trospium chloride) capsules for oral use for the treatment of ...

Outlookindia5d

FDA Approves First New Schizophrenia Drug In 30 Years: Cobenfy Offers Hope With Fewer Side Effects | Details

For the first time in nearly three decades, a new treatment for schizophrenia has been approved by the U.S. Food and Drug Administration (FDA ... high rates of heart disease and premature ...

Time6d

FDA Approves the First New Schizophrenia Drug in Decades

No new treatments for schizophrenia have been approved in nearly three decades, but that changed on Sept. 26, when the U.S. Food and Drug Administration (FDA) approved Cobenfy for the ...

15d

FDA Expands Use of Breast Cancer Drug Kisqali

The FDA approval of Kisqali for this early breast cancer population, including those with NO [hasn't spread to nearby lymph ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results

Trending on Bing